International Journal of Scientific and Research Publications

IJSRP, Volume 12, Issue 10, October 2022 Edition [ISSN 2250-3153]


Sildenafil Citrate – A Potent Solution To Fetal Growth Reduction/ Oligohydramnios
      Dr. Nishtha Gupta
Abstract: Fetal growth restriction (FGR), is a condition where an unborn baby (fetus), is smaller than what is expected for the number weeks of pregnancy (gestational year). This is usually described as a weight that is less than the 10th per centile. It is a baby whose estimated weight is less than the 10th percentile. An AFI that shows a fluid level less than 5 cm (or the 5th percentile) or a lack of fluid pockets 2-3 cm in depth at 32-36-week gestation would indicate oligohydramnios. It vasodilates myometrial arteries, and increases the amniotic fluid quantity. To provide a comprehensive description of sildenafil Citrates use in iugr or oligohydramnios, we reviewed the numerous literature sources.

Reference this Research Paper (copy & paste below code):
Dr. Nishtha Gupta (2022); Sildenafil Citrate – A Potent Solution To Fetal Growth Reduction/ Oligohydramnios; International Journal of Scientific and Research Publications (IJSRP) 12(10) (ISSN: 2250-3153), DOI: http://dx.doi.org/10.29322/IJSRP.12.10.2022.p13012

-->
©️ Copyright 2011-2022 IJSRP - All rights reserved. Use of this web site signifies your agreement to the terms and conditions.